# Extended Infant Post-exposure Prophylaxis With Antiretrovirals to Reduce Postnatal HIV Transmission

> **NCT00115648** · PHASE3 · COMPLETED · sponsor: **Johns Hopkins Bloomberg School of Public Health** · enrollment: 3300 (estimated)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Nevirapine
- **DRUG:** AZT
- **DRUG:** NVP and AZT
- **DRUG:** NVP
- **DRUG:** NVP+AZT

## Key facts

- **NCT ID:** NCT00115648
- **Lead sponsor:** Johns Hopkins Bloomberg School of Public Health
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** 2007-08
- **Final completion:** 2009-10
- **Target enrollment:** 3300 (ESTIMATED)
- **Last updated:** 2014-03-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00115648

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00115648, "Extended Infant Post-exposure Prophylaxis With Antiretrovirals to Reduce Postnatal HIV Transmission". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00115648. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*